2018PubMedOpen access

Liothyronine for Depression: A Review and Guidance for Safety Monitoring.

Karim Yahia Jaffer, Tiffany Chang, Brigitte Vanle, Jonathan Dang, Alexander J. Steiner, Natalie Loera, Marina Abdelmesseh, Itai Danovitch, Waguih William IsHak

Open full text 146 citations

Abstract

A review of the literature suggests that there are adequate data supporting the efficacy and general safety of the low-dose use of trazodone for the treatment of insomnia.

About this research paper

What this paper is about

A review of the literature suggests that there are adequate data supporting the efficacy and general safety of the low-dose use of trazodone for the treatment of insomnia.

Why it matters

OpenAlex reports 146 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A review of the literature suggests that there are adequate data supporting the efficacy and general safety of the low-dose use of trazodone for the treatment of insomnia.

Key concepts: Trazodone, Primary Insomnia, Medicine, Insomnia, Population, Randomized controlled trial, Depression (economics), Psychiatry

Related papers

Back to paper searchBrowse research topicsOriginal source
Liothyronine for Depression: A Review and Guidance for Safety Monitoring. — Research Paper | ScholarLens